Ambeed.cn

首页 / / / Syk / Entospletinib

Entospletinib 99%+

货号:A181632 同义名: GS-9973 Ambeed 开学季,买赠积分,赢豪礼

GS-9973 is a Syk inhibitor with IC50 value of 7.7 nM which is used for the treatment of autoimmune and oncology indications.

Entospletinib 化学结构 CAS号:1229208-44-9
Entospletinib 化学结构
CAS号:1229208-44-9
Entospletinib 3D分子结构
CAS号:1229208-44-9
Entospletinib 化学结构 CAS号:1229208-44-9
Entospletinib 3D分子结构 CAS号:1229208-44-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Entospletinib 纯度/质量文件 产品仅供科研

货号:A181632 标准纯度: 99%+
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell,2024. Ambeed. [ A125712 ]
Cancer Discov., 2024. Ambeed. [ A285925 ]
JMC, 2024, 67(17): 14974-14985. Ambeed. [ A288696 ]
JMC, 2024, 67(17): 15061-15079. Ambeed. [ A524399 , A633512 , A144280 , A174613 ]
EJNMMI Radiopharm. Chem., 2024, 9, 61. Ambeed. [ A1257961 , A622068 ]
更多 >
产品名称 Syk 其他靶点 纯度
PRT062607 HCl ++++

Syk, IC50: 1 nM

99%+
R406 ++

Syk, IC50: 41 nM

98%
Fostamatinib Disodium ++

Syk, IC50: 41 nM

99%+
Piceatannol PKC 98%
BAY 61-3606 2HCl +++

Syk, Ki: 7.5 nM

99+%
Entospletinib +++

Syk, IC50: 7.7 nM

99%+
MNS +

Syk, IC50: 2.5 μM

Src,p97 98%
Fostamatinib ++

Syk, IC50: 41 nM

99%+
RO9021 +++

Syk, IC50: 5.6 nM

98%
TAK-659 HCl ++++

Syk, IC50: 3.2 nM

FLT3 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Entospletinib 生物活性

靶点
  • Syk

    Syk, IC50:7.7 nM

描述 Spleen tyrosine kinase (Syk) is an intracellular cytoplasmic tyrosine kinase that mediates immunoreceptor signaling primarily in hematopoietic cells. GS-9973 is a potent, selective, and orally bioavailable Sky inhibitor with an EC50 value of 26 nM[1]. The level of phosphorylated Akt and ribosomal S6 in primary chronic lymphocytic leukemia (CLL) cells was decreased by 100 nM GS-9973 compared to control cells, while idelalisib and GS-9973 in combination (100 nM each) showed more potent inhibitory effect on Akt and ribosomal S6 phosphorylation. Compared to single agent treatment, the combination of GS-9973 (0.01 - 10 μM) and idelalisib (0.01 - 10 μM) synergistically decreased the cell viability of CLL cells isolated from the peripheral blood or bone marrow[2]. In a rat collagen-induced arthritis model, twice daily oral dosing with GS-9973 at 10, 3, and 1 mg/kg significantly inhibited ankle inflammation. Histological analyses showed that GS-9973 inhibited cartilage damage, bone resorption, pannus formation, and peritosteal bone formation with ED50 values ranging from 1.2 to 3.9 mg/kg[1].
作用机制 GS-9973 is a selective, orally efficacious, imidazopyrazine-based inhibitor of Syk that forms a hydrogen bond with the D512 side chain of Syk kinase[1].

Entospletinib 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
C57BL/6 mouse bone marrow cells Cytotoxic assay 4 days Cytotoxicity against C57BL/6 mouse bone marrow cells assessed as growth inhibition preincubated for 4 days followed by [3H]-thymidine addition measured after 5 hrs by betaplate counting analysis, IC50=0.582 μM 25633741
human MV411 cells Proliferation assay 72 h Inhibition of Flt3 in human MV411 cells assessed as assessed as proliferation after 72 hrs incubation by spectrophotometry, EC50=0.327 μM 24779514

Entospletinib 动物研究

Dose Rat: 1 mg/kg - 10 mg/kg[1] (p.o.) Nude Mice: 20 mg/kg[3] (p.o.)
Administration p.o.
Pharmacokinetics
Animal Rats[1] Dogs[1]
Dose 0.4 mg/kg (i.v.)
1 mg/kg (p.o.)
0.4 mg/kg (i.v.)
1 mg/kg (p.o.)
Administration i.v.
p.o.
i.v.
p.o.
F 67 ± 9% (p.o.) 53 ± 16% (p.o.)
CL 0.27 ± 0.01 L/h/kg (i.v.) 0.80 ± 0.03 L/h/kg (i.v.)
Protein binding (free drug %) 0.992 0.928
Vss 0.52 ± 0.05 L/kg (i.v.) 1.41 ± 0.40 L/kg (i.v.)

Entospletinib 参考文献

[1]Currie KS, Kropf JE, et al. Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. J Med Chem. 2014;57(9):3856-73.

[2]Burke RT, Meadows S, et al. A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor. Oncotarget. 2014;5(4):908-15.

[3]Sun H, Lin DC, et al. Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing Sarcoma. Clin Cancer Res. 2017 Aug 1;23(15):4376-4387.

Entospletinib 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.43mL

0.49mL

0.24mL

12.15mL

2.43mL

1.22mL

24.30mL

4.86mL

2.43mL

Entospletinib 技术信息

CAS号1229208-44-9
分子式C23H21N7O
分子量 411.459
别名 GS-9973
运输蓝冰
存储条件

粉末 Keep in dark place,Inert atmosphere,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 45 mg/mL(109.37 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方

IP 2% DMSO+2% Tween80+30% PEG300+water 0.4 mg/mL clear

PO 0.5% CMC-Na 41 mg/mL suspension

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。